Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Offen

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Behavioural Brain Research|January 7, 2014
Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer's diseaseAdi Shruster, Daniel Offen
Biomolecules|September 18, 2020
Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived ExosomesReut Guy, Daniel Offen
Stem Cells (Dayton, Ohio)|June 8, 2017
Concise Review: Mesenchymal Stem Cells in Neurodegenerative DiseasesRotem Volkman, Daniel Offen
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2020
Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene EditingRoy Rabinowitz, Daniel Offen
Stem Cells and Development|January 17, 2013
Cell and gene therapy in Alzheimer's diseaseMicaela Johanna Glat, Daniel Offen
Apoptosis : an International Journal on Programmed Cell Death|March 27, 2010
Neurogenesis in the aged and neurodegenerative brainAdi Shruster, Eldad Melamed, Daniel Offen
Journal of Molecular Neuroscience : MN|January 19, 2005
Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's diseaseHanoch Elkon, Eldad Melamed, Daniel Offen
Neuroscience Letters|April 6, 2006
Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damageNirit Lev, Eldad Melamed, Daniel Offen
Handbook of Clinical Neurology|September 24, 2008
Toxic causes of parkinsonismNirit Lev, Eldad Melamed, Daniel Offen
Stem Cells (Dayton, Ohio)|July 11, 2009
Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possibleRan Barzilay, Eldad Melamed, Daniel Offen
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Behavioural Brain Research|January 7, 2014
Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer's diseaseAdi Shruster, Daniel Offen
Biomolecules|September 18, 2020
Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived ExosomesReut Guy, Daniel Offen
Stem Cells (Dayton, Ohio)|June 8, 2017
Concise Review: Mesenchymal Stem Cells in Neurodegenerative DiseasesRotem Volkman, Daniel Offen
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 28, 2020
Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene EditingRoy Rabinowitz, Daniel Offen
Stem Cells and Development|January 17, 2013
Cell and gene therapy in Alzheimer's diseaseMicaela Johanna Glat, Daniel Offen
Apoptosis : an International Journal on Programmed Cell Death|March 27, 2010
Neurogenesis in the aged and neurodegenerative brainAdi Shruster, Eldad Melamed, Daniel Offen
Journal of Molecular Neuroscience : MN|January 19, 2005
Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's diseaseHanoch Elkon, Eldad Melamed, Daniel Offen
Neuroscience Letters|April 6, 2006
Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damageNirit Lev, Eldad Melamed, Daniel Offen
Handbook of Clinical Neurology|September 24, 2008
Toxic causes of parkinsonismNirit Lev, Eldad Melamed, Daniel Offen
Stem Cells (Dayton, Ohio)|July 11, 2009
Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possibleRan Barzilay, Eldad Melamed, Daniel Offen
Pageof 14